Position in DFTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$867,888
+$765,564 QoQ
Shares Held
18,450
+240.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#178
of 358 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DFTX Over Time
Shares Held
Position Value (USD)
Derivatives in DFTX
reported options exposure · as of Jun 30, 2026CallValue
$550,368
CallShares
11,700
PutValue
$122,304
PutShares
2,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Trading LLC holds $28,211,005 across 28 Biotechnology names. DFTX ranks #9 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,407 | $7,112,720 | |
| 2 | MRNA |
Moderna, Inc.
|
101,066 | $7,077,651 | |
| 3 | BNTX |
BioNTech SE
|
25,690 | $2,390,454 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,037 | $1,817,318 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
33,938 | $1,323,921 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
19,679 | $1,081,164 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
18,595 | $1,014,171 | |
| 8 | ABVX |
Abivax S.A.
|
6,790 | $904,835 |
All Filings in DFTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $550,368 | 11,700 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $867,888 | 18,450 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $122,304 | 2,600 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $102,324 | 5,414 | Shares | Sole | 2026-05-11 | |
| 2026-03-31 | $103,950 | 5,500 | Call | Sole | 2026-05-11 | |
| 2026-03-31 | $58,590 | 3,100 | Put | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||